Cargando…

The ferroptosis and iron-metabolism signature robustly predicts clinical diagnosis, prognosis and immune microenvironment for hepatocellular carcinoma

BACKGROUND: In this study, we comprehensively analyzed genes related to ferroptosis and iron metabolism to construct diagnostic and prognostic models and explore the relationship with the immune microenvironment in HCC. METHODS: Integrated analysis, cox regression and the least absolute shrinkage an...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tang, Bufu, Zhu, Jinyu, Li, Jie, Fan, Kai, Gao, Yang, Cheng, Shimiao, Kong, Chunli, Zheng, Liyun, Wu, Fazong, Weng, Qiaoyou, Lu, Chenying, Ji, Jiansong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2020
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592541/ https://www.ncbi.nlm.nih.gov/pubmed/33115468 http://dx.doi.org/10.1186/s12964-020-00663-1

Ejemplares similares

Integrative analysis of the molecular mechanisms, immunological features and immunotherapy response of ferroptosis regulators across 33 cancer types
por: Tang, Bufu, et al.
Publicado: (2022)

A role for the NPM1/PTPN14/YAP axis in mediating hypoxia-induced chemoresistance to sorafenib in hepatocellular carcinoma
por: Zhang, Dengke, et al.
Publicado: (2022)

Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma
por: Lu, Chenying, et al.
Publicado: (2020)

Correction to: Integrated analysis reveals critical glycolytic regulators in hepatocellular carcinoma
por: Lu, Chenying, et al.
Publicado: (2020)

A Radiomics Signature-Based Nomogram to Predict the Progression-Free Survival of Patients With Hepatocellular Carcinoma After Transcatheter Arterial Chemoembolization Plus Radiofrequency Ablation
por: Fang, Shiji, et al.
Publicado: (2021)

CircSOD2 induced epigenetic alteration drives hepatocellular carcinoma progression through activating JAK2/STAT3 signaling pathway
por: Zhao, Zhongwei, et al.
Publicado: (2020)

Diagnosis and prognosis models for hepatocellular carcinoma patient’s management based on tumor mutation burden
por: Tang, Bufu, et al.
Publicado: (2021)

Therapeutic Potential of Triptolide as an Anti-Inflammatory Agent in Dextran Sulfate Sodium-Induced Murine Experimental Colitis
por: Tang, Bufu, et al.
Publicado: (2020)

Identifying Apoptosis-Related Transcriptomic Aberrations and Revealing Clinical Relevance as Diagnostic and Prognostic Biomarker in Hepatocellular Carcinoma
por: Zhu, Jinyu, et al.
Publicado: (2021)

TACE responser NDRG1 acts as a guardian against ferroptosis to drive tumorgenesis and metastasis in HCC
por: Tang, Bufu, et al.
Publicado: (2023)

A hypoxia-related signature for clinically predicting diagnosis, prognosis and immune microenvironment of hepatocellular carcinoma patients
por: Zhang, Baohui, et al.
Publicado: (2020)

Efficacy and Safety of TACE Combined With Sorafenib Plus Immune Checkpoint Inhibitors for the Treatment of Intermediate and Advanced TACE-Refractory Hepatocellular Carcinoma: A Retrospective Study
por: Zheng, Liyun, et al.
Publicado: (2021)

Targeted xCT‐mediated Ferroptosis and Protumoral Polarization of Macrophages Is Effective against HCC and Enhances the Efficacy of the Anti‐PD‐1/L1 Response
por: Tang, Bufu, et al.
Publicado: (2022)

Predictive Models for HCC Prognosis, Recurrence Risk, and Immune Infiltration Based on Two Exosomal Genes: MYL6B and THOC2
por: Zhu, Jinyu, et al.
Publicado: (2021)

Identification and validation of the angiogenic genes for constructing diagnostic, prognostic, and recurrence models for hepatocellular carcinoma
por: Zhu, Jinyu, et al.
Publicado: (2020)

Emerging Mechanisms and Targeted Therapy of Ferroptosis in Neurological Diseases and Neuro-oncology
por: Wang, Yajie, et al.
Publicado: (2022)

Ferroptosis-related lncRNA signature predicts the prognosis and immune microenvironment of hepatocellular carcinoma
por: Fang, Chongkai, et al.
Publicado: (2022)

SMYD3 associates with the NuRD (MTA1/2) complex to regulate transcription and promote proliferation and invasiveness in hepatocellular carcinoma cells
por: Yang, Yang, et al.
Publicado: (2022)

The Effect of m6A Methylation Regulatory Factors on the Malignant Progression and Clinical Prognosis of Hepatocellular Carcinoma
por: Zhao, Zhongwei, et al.
Publicado: (2020)

A radiomic nomogram based on arterial phase of CT for differential diagnosis of ovarian cancer
por: Hu, Yumin, et al.
Publicado: (2021)

The ferroptosis signature predicts the prognosis and immune microenvironment of nasopharyngeal carcinoma
por: Zhou, Ji, et al.
Publicado: (2023)

CPEB1 mediates hepatocellular carcinoma cancer stemness and chemoresistance
por: Xu, Min, et al.
Publicado: (2018)

A Ferroptosis and Pyroptosis Molecular Subtype-Related Signature Applicable for Prognosis and Immune Microenvironment Estimation in Hepatocellular Carcinoma
por: Huo, Junyu, et al.
Publicado: (2021)

USP9X promotes apoptosis in cholangiocarcinoma by modulation expression of KIF1Bβ via deubiquitinating EGLN3
por: Chen, Weiqian, et al.
Publicado: (2021)

The Landscape of Coronavirus Disease 2019 (COVID-19) and Integrated Analysis SARS-CoV-2 Receptors and Potential Inhibitors in Lung Adenocarcinoma Patients
por: Tang, Bufu, et al.
Publicado: (2020)

A Ferroptosis-Related Signature Robustly Predicts Clinical Outcomes and Associates With Immune Microenvironment for Thyroid Cancer
por: Ge, Mingqin, et al.
Publicado: (2021)

Comprehensive characterization of ferroptosis in hepatocellular carcinoma revealing the association with prognosis and tumor immune microenvironment
por: Zhu, Jingjuan, et al.
Publicado: (2023)

Construction and validation of a robust ferroptosis-associated gene signature predictive of prognosis in lung adenocarcinoma
por: Zhou, Mi, et al.
Publicado: (2022)

Predictive Models for Colon Adenocarcinoma Diagnosis, Prognosis, and Immune Microenvironment Based on 2 Hypoxia-Related Genes: KDM3A and ENO3
por: Kong, Chunli, et al.
Publicado: (2023)

A Ferroptosis-Related lncRNAs Signature Predicts Prognosis and Immune Microenvironment for Breast Cancer
por: Zhang, Kaiming, et al.
Publicado: (2021)

Development and validation of a ferroptosis-related lncRNAs signature to predict prognosis and microenvironment for melanoma
por: Ping, Shuai, et al.
Publicado: (2022)

Identification of a novel gene signature with regard to ferroptosis, prognosis prediction, and immune microenvironment in osteosarcoma
por: Zheng, Di, et al.
Publicado: (2022)

xCT contributes to colorectal cancer tumorigenesis through upregulation of the MELK oncogene and activation of the AKT/mTOR cascade
por: Tang, Bufu, et al.
Publicado: (2022)

Computational Identification of Immune- and Ferroptosis-Related LncRNA Signature for Prognosis of Hepatocellular Carcinoma
por: Huang, Anmin, et al.
Publicado: (2021)

Ferroptosis-related long non-coding RNA signature predicts the prognosis of hepatocellular carcinoma
por: Yang, Xin, et al.
Publicado: (2022)

Development and validation of an immune‐related prognosis signature associated with hypoxia and ferroptosis in hepatocellular carcinoma
por: Yang, Chun‐Bo, et al.
Publicado: (2022)

A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma
por: Ouyang, Guoqing, et al.
Publicado: (2020)

Construction and validation of a novel ferroptosis-related signature for evaluating prognosis and immune microenvironment in ovarian cancer
por: Yang, Jiani, et al.
Publicado: (2023)

Molecular subtyping of acute myeloid leukemia through ferroptosis signatures predicts prognosis and deciphers the immune microenvironment
por: Fu, Denggang, et al.
Publicado: (2023)

Identification and validation of a ferroptosis-related lncRNA signature to robustly predict the prognosis, immune microenvironment, and immunotherapy efficiency in patients with clear cell renal cell carcinoma
por: Ju, Lincheng, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_pivkc4amtfgmc0u038ukb559pg